The Ahmanson Translational Imaging Division of the Department of Molecular and Medical Pharmacology at the David Geffen School of Medicine at UCLA is currently recruiting an attending physician at the Assistant Professor level to serve in the nuclear medicine clinic of the Ronald Reagan Hospital and the David Geffen School of Medicine at UCLA.
The candidate must hold an M.D. degree and is expected to contribute significantly to the clinical and translational research programs in molecular imaging and therapy. The candidate must have documented clinical experience in nuclear medicine and oncological imaging. Experience in clinical therapeutic nuclear medicine applications is required as part of the Division’s integration of molecular imaging diagnostics and therapeutics. Receptor based imaging experience (neuroendocrine tumors) is a condition for appointment. Although not required, there is a particular interest in receptor-based radiotherapy treatments of neuro-endocrine tumors.
A publication record in clinical PET/CT imaging research commensurate with the Assistant Clinical Professor level is desirable.
The Ahmanson Translational Imaging Division has well-equipped imaging probe and drug discovery labs, molecular & cell biology labs, two Siemens RDS self-shielded cyclotrons and radiochemistry facilities, preclinical PET/CT and bioluminescence imaging systems and clinical PET/CT and SPECT/CT. The Division also has well-established clinical programs and collegial relationships with the Jonsson Comprehensive Cancer Center and the Departments of Urology, Radiation Oncology, Radiology, Medicine, Surgery and Neurology that are important to the success of the selected candidate for this position.
Candidates should submit a letter of interest and CV addressed to: Chair of the Search Committee, Ahmanson Translational Imaging Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA via UCLA Academic Recruit ( https://recruit.apo.ucla.edu/JPF04975), and arrange to have a statement of research accomplishments and a research plan appropriate for the position, and three letters of recommendation sent to the same address. Letters of recommendation should address the candidate’s scholarly and clinical activity.
The University of California is an Equal Opportunity/Affirmative Action Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, age or protected veteran status. For the complete University of California nondiscrimination and affirmative action policy see:
We welcome candidates whose experience in teaching, research, or community service has prepared them to contribute to our commitment to diversity and excellence.
Internal Number: JPF04975
About Department of Molecular and Medical Pharmacology
The Department of Molecular and Medical Pharmacology (DMMP) is a combined basic science and clinical department. The DMMP integrates mathematics, engineering, physical, biological and medical sciences to achieve together advances that we cannot achieve individually in three overall areas: (1) understanding biology of disease, (2) developing new molecular diagnostics and (3) developing new molecular and cellular therapeutics.The DMMP offers an opportunity for students, postdocs, medical fellows, and basic and clinical faculty to explore together the molecular and biological mechanisms that regulate cellular and organ functions to (1) identify and understand molecular errors of disease, (2) develop means to diagnose and monitor disease, and (3) develop pharmacological means to correct these errors. Within the DMMP are the preclinical Crump Institute for Molecular Imaging (CIMI) and the Ahmanson Translational Imaging Division (ATID). Within ATID, with its Nuclear Medicine and PET imaging research and clinical service, students have access to state-of-the-art science and technology to directly impact patient care.